Drug
ORMD-0801 clinical trials
Also written ORMD-0801.
- studies test it
- 10
- open now
- 1
- in phase 3
- 3
- first study started
- 2008
Keep track of what changes. Save the ORMD-0801 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
10 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 7
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 2
Oramed, Ltd. (8) · Hadassah Medical Organization (1) · King Hamad University Hospital, Bahrain (1)
Studies
Open first, then newest update. How each study uses ORMD-0801 is read from its arms, and is right about nine times in ten.
Testing it · 10
- A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus.Not yet recruitingPhase 3Oramed, Ltd.NCT06731075Written as ORMD-0801 8 mg
- A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)CompletedPhase 2Oramed, Ltd.NCT04618744Written as ORMD-0801 (Insulin) capsule 8 mg BD
- A Study to Evaluate the Effect of ORMD-0801 in Patients With Type 2 Diabetes MellitusCompletedPhase 2Oramed, Ltd.NCT04564846Written as ORMD-0801
- A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes MellitusTerminatedPhase 3Oramed, Ltd.NCT04754334Written as ORMD-0801
- A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes MellitusCompletedPhase 2Oramed, Ltd.NCT03467932Written as Cohort A: ORMD-0801
- Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes MellitusStatus unknownPhase 3King Hamad University Hospital, BahrainNCT04817215Written as ORMD-0801
- Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes MellitusCompletedPhase 2Oramed, Ltd.NCT02496000Written as ORMD-0801
- A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes MellitusCompletedPhase 2Oramed, Ltd.NCT02954601Written as ORMD-0801 (qd)
- A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 DiabeticsCompletedPhase 2Oramed, Ltd.NCT02094534Written as ORMD-0801 Capsules
- Effectiveness of Oral Insulin in Unstable Type 1 Diabetes PatientsCompletedPhase 2Hadassah Medical OrganizationNCT00867594Written as ORMD 0801